State litigation guide · Massachusetts

Hernia Mesh (Davol/C.R. Bard) Lawsuit in Massachusetts

Time limits apply in Massachusetts. Find out if you still qualify.

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

People's Justice Research TeamUpdated June 11, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Statute of limitations — Massachusetts

Massachusetts M.G.L. c. 260 § 2A provides a 3-year limitations period for tort claims. Massachusetts applies the discovery rule. The Massachusetts statute of repose for tort actions is also 3 years from discovery under M.G.L. c. 260 § 2A — the SOL and repose effectively coincide. Massachusetts courts apply the discovery rule to medical device claims, but the 3-year window is firm once discovery is established.

3 years from discovery

Massachusetts data

Exposure in Massachusetts

Boston is home to Mass General, Brigham and Women's, and Beth Israel Deaconess — institutions where complex mesh revision surgeries including explantation are routinely performed

World-class surgical centers

Source: Massachusetts hospital quality data

Massachusetts's 3-year SOL runs from discovery — once a physician attributes symptoms to the mesh, the clock is running with no additional repose extension

3-year firm deadline

Source: M.G.L. c. 260 § 2A case law

Estimated annual hernia repair surgeries in Massachusetts

~20,000

Source: Massachusetts Center for Health Information and Analysis

Medical resources

Clinics & Specialists in Massachusetts

Massachusetts General Hospital — Hernia Surgery Program, Department of Surgery

Brigham and Women's Hospital — Division of General Surgery

FAQ

Frequently Asked Questions

12 QUESTIONS

Hernia mesh litigation is a mass tort action against manufacturers of defective synthetic mesh implants used in hernia repair surgery. The primary defendants are Davol Inc. and C.R. Bard (now part of Becton Dickinson), Ethicon (a subsidiary of Johnson and Johnson), Atrium Medical, and Covidien (now part of Medtronic). These companies manufactured polypropylene and composite mesh devices that have been associated with serious complications including mesh migration, adhesion, infection, chronic pain, and bowel obstruction. Thousands of patients have filed claims in MDL 2846 in the Southern District of Ohio and in state court coordinations.

Keep reading